Kieffer Tara Lynn

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$128,454.51

Insider Activity of Kieffer Tara Lynn

According to the SEC Form 4 filings, Kieffer Tara Lynn, being in a position of

  1. Chief Product Strategy Officer at Enanta Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 9549 shares for $107,991,
    over all time since 2023-12-05, has bought 0 shares, and sold 11674 shares for $128,455.

The largest sale of all time was on 2024-06-17 and amounted to 7266 shares of Enanta Pharmaceuticals, Inc. for $89,590.

Biography of Kieffer Tara Lynn

No biography is available at this moment.

2024-12-06SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Product Strategy Officer
2,283
0.0108%
$8.06$18,401-21.13%
2024-06-17SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Product Strategy Officer
7,266
0.0315%
$12.33$89,590-4.64%
2023-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP, New Prod. Strat. & Dev
2,125
0.0103%
$9.63$20,464+31.04%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.